Randomized n-of-1 Trials: Quality Improvement, Research, or Both?

Related Articles

Randomized n-of-1 Trials: Quality Improvement, Research, or Both?

Pediatrics. 2016 Aug;138(2):

Authors: Samuel JP, Burgart A, Wootton SH, Magnus D, Lantos JD, Tyson JE

Abstract
The regulatory demarcations between clinical research and quality improvement (QI) are ambiguous and controversial. Some projects that were undertaken as a form of QI were deemed by regulatory agencies to be research and thus to require institutional review board approval. In the era of personalized medicine, some physicians may ask some patients to participate in n-of-1 trials in an effort to personalize and optimize each patient's medical treatment. Should such activities be considered research, QI, or just excellent personalized medicine? Experts in research, research regulation, and bioethics analyze these issues.

PMID: 27385811 [PubMed - indexed for MEDLINE]

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2tsmqkS
via IFTTT